| Literature DB >> 12132141 |
M S van Noorden1, A C M Vergouwen, G F Koerselman.
Abstract
A 35-year-old man with anxiety and depression who was treated with venlafaxine, 300 mg a day, developed severe withdrawal symptoms in the form of a delirium during gradual tapering of the dosage. The symptoms resolved when the dosage was kept constant and did not recur when the dosage was reduced more gradually. Withdrawal symptoms are common during discontinuation of antidepressants, particularly after prolonged use of agents with a short half-life. The symptoms are usually mild and transient, especially in the case of selective serotonin reuptake inhibitors and venlafaxine. The occurrence of delirium as a result of the withdrawal of venlafaxine has not been reported previously. Even when antidepressants are being withdrawn with care, one should remain alert to the possible development of severe withdrawal symptoms.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12132141
Source DB: PubMed Journal: Ned Tijdschr Geneeskd ISSN: 0028-2162